DDW’s Megan Thomas speaks with Dr Chantale Bernatchez, Director of Cell Therapy Process Development at CTMC, about tumour infiltrating lymphocyte (TIL) therapy and what’s on the horizon for this new class of cell therapy.
Article Link: https://www.ddw-online.com/ddw-fall-2024-31591-202409/